Hsieh Mu-Yang, Luo Chien-Ming, Cheng Chi-Hong, Dai Li-Pei, Chen Chiu-Hui, Chuang Shao-Yuan, Yang Chung-Wei, Wu Chih-Cheng
College of Medicine, National Taiwan University, Taipei, Taiwan.
Department of Medicine, Cardiology Division, National Taiwan University Hospital, Hsin-Chu Hospital, Hsin-Chu, Taiwan.
Aging (Albany NY). 2024 Dec 31;16(22):13676-13692. doi: 10.18632/aging.206178.
Chronic limb-threatening ischemia (CLTI) is a prevalent yet unpredictable complication among patients undergoing hemodialysis, and frailty is linked to adverse outcomes in this population. This study examined the influence of clinical factors on vascular events in patients undergoing hemodialysis. This multicenter prospective cohort study included patients undergoing maintenance hemodialysis since January 2008. The initial cohort consisted of 1,136 patients, 828 of whom successfully underwent a frailty test. CLTI events were recorded at 3-month intervals until December 31, 2022. The mean patient age was 67 years, and 48% were female. Overall, 34% of participants were frail, 38% pre-frail, and 28% not frail. Frailty phenotype was associated with age, female sex, low educational level, diabetes mellitus, and history of stroke. During a median follow-up of 1461 days, 104 patients experienced CLTI events (not frail, 6.5%; pre-frail, 11%; frail, 20%; < 0.001). Frail patients had a higher risk of CLTI than those who were non-frail (hazard ratio (HR) 3.94; 95% confidence interval (CI) 2.22-6.99; < 0.001). After multivariable adjustment for age and comorbidities, frailty remained significantly associated with CLTI (HR 3.26; 95% CI 1.76-5.85; < 0.001). Conclusively, these findings highlight the risk of CLTI in frail patients undergoing hemodialysis.
慢性肢体威胁性缺血(CLTI)是接受血液透析患者中普遍存在但不可预测的并发症,且衰弱与该人群的不良结局相关。本研究探讨了临床因素对接受血液透析患者血管事件的影响。这项多中心前瞻性队列研究纳入了自2008年1月起接受维持性血液透析的患者。初始队列由1136名患者组成,其中828名成功接受了衰弱测试。CLTI事件每3个月记录一次,直至2022年12月31日。患者平均年龄为67岁,48%为女性。总体而言,34%的参与者为衰弱,38%为衰弱前期,28%为非衰弱。衰弱表型与年龄、女性、低教育水平、糖尿病和中风病史相关。在中位随访1461天期间,104名患者发生了CLTI事件(非衰弱,6.5%;衰弱前期,11%;衰弱,20%;<0.001)。衰弱患者发生CLTI的风险高于非衰弱患者(风险比(HR)3.94;95%置信区间(CI)2.22 - 6.99;<0.001)。在对年龄和合并症进行多变量调整后,衰弱仍与CLTI显著相关(HR 3.26;95% CI 1.76 - 5.85;<0.001)。总之,这些发现凸显了接受血液透析的衰弱患者发生CLTI的风险。